Details for United Kingdom Supplementary Protection Certificate: SPC/GB99/029
✉ Email this page to a colleague
Country | Patent Number | Supplementary Protection Certificate | SPC Country | SPC Description | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 0451216 | SPC/GB99/029 | United Kingdom | PRODUCT NAME: DACLIZUMAB OR ITS PHARMACEUTICALLY ACCEPTABLE FORMS; REGISTERED: CH IKS 5458301 19980303; UK EU/1/99/098/001 19990226; UK EU/1/99/098/002 19990226 | ⤷ Try a Trial |